全球首台磁共振引导放疗系统两年半临床经验
该研究回顾性分析了2014年1月至2016年6月前瞻性登记的使用全球首台MR-IGRT系统治疗的患者,共316例,常见部位为腹部、乳腺、盆腔、胸部及头颈,部分患者接受在线自适应放疗或电影门控。结果表明MR-IGRT可成功整合于高容量放疗临床,并为多种恶性肿瘤提供独特优势。
要点
- MR-IGRT系统已成功用于316例患者,最常见治疗部位为腹部(28%)和乳腺(26%)。
核心结论
- MR-IGRT已成功在高容量放疗临床中实施,为多种恶性肿瘤治疗提供独特优势。
研究设计与样本
- 前瞻性登记2014年1月至2016年6月使用全球首台MR-IGRT系统治疗的患者,系统为0.35T磁共振扫描仪与3个60Co机头整合。
主要发现
- 共治疗316例患者,病例选择最常见原因为改善软组织显像、自适应放疗和电影门控。
- 治疗部位分布为腹部28%、乳腺26%、盆腔22%、胸部19%、头颈5%。
临床怎么用
- MR-IGRT可用于需要改善软组织显像、在线自适应或电影门控的患者,并整合于高容量临床流程。
局限性
- 本文为单中心前瞻性登记的经验报告,未报告疗效或毒性比较结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Magnetic resonance image guided radiation therapy (MR-IGRT) has been used at our institution since 2014. We report on more than 2 years of clinical experience in treating patients with the world's first MR-IGRT system. METHODS AND MATERIALS: A clinical service was opened for MR-IGRT in January 2014 with an MR-IGRT system consisting of a split 0.35T magnetic resonance scanner that straddles a ring gantry with 3 multileaf collimator-equipped 60Co heads. The service was expanded to include online adaptive radiation therapy (ART) MR-IGRT and cine gating after 6 and 9 months, respectively. Patients selected for MR-IGRT were enrolled in a prospective registry between January 2014 and June 2016. Patients were treated with a variety of radiation therapy techniques including intensity modulated radiation therapy and stereotactic body radiation therapy (SBRT). When applicable, online ART was performed and gating on sagittal 2-dimensional cine MR was used. The charts of patients treated with MR-IGRT were reviewed to report on the clinical and treatment characteristics of the initial patients who were treated with this novel technique. RESULTS: A total of 316 patients have been treated with the MR-IGRT system, which has been integrated into a high-volume clinic. The cases were most commonly selected for improved soft tissue visualization, ART, and cine gating. Seventy-six patients were treated with 3-dimensional conformal radiation therapy, 146 patients with intensity modulated radiation therapy, and 94 patients with SBRT. The most commonly treated disease sites were the abdomen (28%), breast (26%), pelvis (22%), thorax (19%), and head and neck (5%). Sixty-seven patients were treated with online ART over a total of 244 adapted fractions. Cine treatment gating was used for a total of 81 patients. CONCLUSIONS: MR-IGRT has been successfully implemented in a high-volume radiation clinic and provides unique advantages in the treatment of a variety of malignancies. Additional clinical trials are in development to formally evaluate MR-IGRT in the treatment of multiple disease sites with techniques such as SBRT and ART.
引用
- Fischer-Valuck BW, Henke L, Green O, et al. Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system. Adv Radiat Oncol. 2017. PMID: 29114617. doi:10.1016/j.adro.2017.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。